CRSP catalysts
Catalysts and events linked to CRSP, newest first.
DateCardAvg 5d
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients Aged 2+CRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP
- 2026-09-09CRISPR Therapeutics Casgevy Sales Surge 78% QoQ to $76M Following FDA ExpansionCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
- 2026-09-09FDA Approves Label Expansion for CRISPR Therapeutics Gene Therapy CasgevyCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP
- 2026-09-09CRISPR Therapeutics Casgevy Sales Surge 78% QoQ to $76M Following FDA ExpansionCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
- 2026-09-09CRISPR Therapeutics reports 78 percent QoQ Casgevy sales growth to $76MCRSP VRTX-1.51%
- 2026-09-09FDA Approves Label Expansion for CRISPR Therapeutics Gene Therapy CasgevyCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Pediatric Label After 78% QoQ Sales JumpCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Gains FDA Pediatric Approval for Casgevy as Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Pediatric Label After 78% QoQ Sales JumpCRSP VRTX-1.51%
- 2026-09-09CRISPR Casgevy sales rise 78% QoQ to $76M following FDA label expansionCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Gains FDA Pediatric Approval for Casgevy as Sales Hit $76MCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label and Posts 78% Sequential Revenue GrowthCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Casgevy Q2 Sales Surge 78% QoQ to $76M on Pediatric LabelCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients Aged 2+CRSP VRTX-1.51%
- 2026-09-09FDA Approves Label Expansion for CRISPR Therapeutics Gene Therapy CasgevyCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics Casgevy Sales Surge 78% QoQ to $76M Following FDA ExpansionCRSP VRTX-1.51%
- 2026-09-09CRISPR Therapeutics reports 78 percent QoQ Casgevy sales growth to $76MCRSP VRTX-1.51%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.